Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

...dispensing Brilacidin via IV will be systemic with

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Justfactsmam Member Profile
Member Level 
Followed By 105
Posts 7,986
Boards Moderated 0
Alias Born 02/09/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:02:03 AM
Annual Report (10-k) Edgar (US Regulatory) - 9/14/2020 4:51:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/4/2020 9:32:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 9:30:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2020 10:01:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 3:10:16 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/20/2020 6:03:30 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/15/2020 10:56:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/10/2020 5:09:32 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/10/2020 3:07:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:28:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 2:16:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2020 9:33:35 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 9:03:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 9:30:58 AM
Cannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here! InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 2:21:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2020 4:39:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 12:00:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2020 12:01:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/27/2020 12:01:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2020 4:06:02 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/13/2020 4:02:49 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/26/2019 5:19:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/26/2019 5:16:58 PM
Justfactsmam Member Level  Friday, 05/22/20 02:18:55 PM
Re: Luckytouch post# 298247
Post # of 324451 
...dispensing Brilacidin via IV will be systemic with Covid-19.

It has already been proven to be effective in the area of infectious disease, Acute Bacterial Skin and Skin Structure Infection (ABSSSI) which was the target indication.

...and it cleared condition in ONE DRIP DOSE.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences